反応式
N1C=C[CH:4]=[CH:3][C:2]=1[CH:7]([N:9]1[CH2:14][CH2:13][N:12]([C:15]([O:17][C:18]([CH3:21])([CH3:20])[CH3:19])=[O:16])[CH2:11][CH2:10]1)[CH3:8].[N:22]1C=CC(C(O)C)=[CH:24][CH:23]=1.C(N(CC)CC)C.CS(Cl)(=O)=O.C(N1CCNCC1)(OC(C)(C)C)=O>CCOC(C)=O.CO.CS(C)=O.C(Cl)Cl>[N:22]1[CH:4]=[CH:3][C:2]([CH:7]([N:9]2[CH2:10][CH2:11][N:12]([C:15]([O:17][C:18]([CH3:19])([CH3:20])[CH3:21])=[O:16])[CH2:13][CH2:14]2)[CH3:8])=[CH:24][CH:23]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 3
実験手順
This was prepared using the same procedure as for tert-butyl 4-(1-(pyridin-2-yl)ethyl)piperazine-1-carboxylate, but here using 1-(pyridin-4-yl)ethanol (J. Chem. Soc., Perkin Trans. 1, 2000, 4439-4444) (100 mg, 0.81 mmol), triethylamine (5.0 eq, 4.05 mmol, 0.56 mL), MsCl (2.0 eq, 1.62 mmol, 0.13 mL), CH2Cl2 (4 mL) at 0° C. for 30 minutes, then N—BOC piperazine (4.0 eq, 3.24 mmol, 605 mg), DMSO (3 mL) at 60° C. for 18 h. Work up as described for tert-butyl 4-(1-(pyridin-2-yl)ethyl)piperazine-1-carboxylate, followed by column chromatography (EtOAc-MeOH, 95:5) gave the product (163 mg, 69% for two steps) as a colourless oil; 1H-NMR (500 MHz, CDCl3) 1.50 (s, 9H, C(CH3)3), 1.72 (s, br, 3H, CH3), 2.42-2.60 (m, 4H, piperazine N(CH2)2), 3.49 (s, br, 5H, CH & piperazine N(CH2)2), 7.32 (d, J=5.7 Hz, 2H, pyridine H-3 & H-5), 8.59 (d, J=5.7 Hz, 2H, pyridine H-2 & H-6);
後処理
- customThis was prepared
- customat 0° C.
- customfor 30 minutes
- customgave the product (163 mg, 69% for two steps) as a colourless oil
出典と根拠
- ORDレコード
- ord-b9b7d9100cc74dae9ea321106d3a7f6a
- 出典データセット
- uspto-grants-2012_01
- 特許番号
- US08088761B2
関連ノート
読み込み中…